Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care

Journal of the Endocrine Society
Jacob C HartzSamuel Gidding

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM). It is estimated that the risk of CVD in diabetes mellitus (DM) is 2 to 10 times higher than in the general population. Much of this increased risk is thought to be related to the development of an atherogenic lipid profile, in which hypertriglyceridemia is an essential component. Recent studies suggest that dyslipidemia may be present in children and adolescents with DM, particularly in T2DM and in association with poor control in T1DM. However, the role of hypertriglyceridemia in the development of future CVD in youth with DM is unclear, as data are scarce. In this review, we will evaluate the pathophysiology of atherogenic hypertriglyceridemia in DM, the evidence regarding an independent role of triglycerides in the development of CVD, and the treatment of hypertriglyceridemia in patients with DM, highlighting the potential relevance to children and the need for more data in children and adolescents to guide clinical practice.

References

Dec 1, 1986·Journal of the American College of Cardiology·P L CannerW Friedewald
Jan 1, 1985·Archives of Disease in Childhood·K A WheelerJ Barley
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jun 1, 1996·The American Journal of Cardiology·G AssmannA von Eckardstein
Oct 29, 2000·The American Journal of Gastroenterology·S NairC S Pitchumoni
Oct 29, 2000·The American Journal of Cardiology·P Cullen
Mar 10, 2001·The Journal of Clinical Endocrinology and Metabolism·I J Goldberg
Apr 13, 2001·JAMA : the Journal of the American Medical Association·S J RobinsUNKNOWN VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial
Nov 20, 2002·Circulation·Penny M Kris-EthertonUNKNOWN American Heart Association. Nutrition Committee
Jan 30, 2004·Diabetes Care·Sabita S Soedamah-MuthuUNKNOWN EURODIAB Prospective Complications Study Group
Jun 1, 2005·Archives of Medical Research·Henry N GinsbergAntonio Hernandez-Ono
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Nov 2, 2006·Current Medical Research and Opinion·Allen J TaylorLance E Sullenberger
Apr 3, 2007·Lancet·Mitsuhiro YokoyamaUNKNOWN Japan EPA lipid intervention study (JELIS) Investigators
Jun 16, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·H J AvisB A Hutten
Jul 11, 2007·Current Opinion in Lipidology·John R Guyton
Jul 20, 2007·JAMA : the Journal of the American Medical Association·Børge G NordestgaardAnne Tybjaerg-Hansen
Jul 20, 2007·The Cochrane Database of Systematic Reviews·L NieldC D Summerbell
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Feb 19, 2008·Journal of the American College of Cardiology·Michael MillerUNKNOWN PROVE IT-TIMI 22 Investigators
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Jun 21, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Martin AdielsJan Borén
Feb 28, 2009·The New England Journal of Medicine·Frank M SacksDonald A Williamson
Nov 12, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
Jan 13, 2010·Archives of Internal Medicine·Thomas F Whayne
Mar 17, 2010·The New England Journal of Medicine·Henry N GinsbergRobert P Byington
May 11, 2010·Lancet·UNKNOWN Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors CollaborationJohn Danesh
Jul 20, 2010·Thrombosis Research·Sara TehraniGun Jörneskog
Aug 13, 2010·The New England Journal of Medicine·Christoph H SaelyHeinz Drexel
Sep 17, 2010·The New England Journal of Medicine·William J Perkins

❮ Previous
Next ❯

Citations

Jan 1, 2020·International Journal of Molecular Sciences·Amélie I S Sobczak, Alan J Stewart
Dec 21, 2021·The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology·Hesham Salah El Din TahaMirna Mamdouh Shaker

❮ Previous
Next ❯

Methods Mentioned

BETA
amputations

Software Mentioned

AIM
LIPID
Google Scholar
HIGH

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.